<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1681-150X</journal-id>
<journal-title><![CDATA[SA Orthopaedic Journal]]></journal-title>
<abbrev-journal-title><![CDATA[SA orthop. j.]]></abbrev-journal-title>
<issn>1681-150X</issn>
<publisher>
<publisher-name><![CDATA[CHAR Publications]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1681-150X2012000100009</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Is procalcitonin useful in diagnosing septic arthritis and osteomyelitis in children?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Greeff]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of the Free State Department of Orthopaedics ]]></institution>
<addr-line><![CDATA[Bloemfontein ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2012</year>
</pub-date>
<volume>11</volume>
<numero>1</numero>
<fpage>52</fpage>
<lpage>56</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_arttext&amp;pid=S1681-150X2012000100009&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_abstract&amp;pid=S1681-150X2012000100009&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_pdf&amp;pid=S1681-150X2012000100009&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[BACKGROUND: Early diagnosis of septic arthritis (SA) and osteomyelitis (OM) in children is essential to prevent long-term sequelae. The diagnosis for these orthopaedic emergencies can be difficult and challenging especially in infants. Standard blood tests used for diagnosis have a low specificity. Procalcitonin (PCT) is significantly elevated in bacterial infections and remains low in viral infections and inflammatory conditions. Good positive predictive values for PCT have been obtained in various studies used in paediatric infections but limited studies have examined the role in orthopaedic infections. METHOD: All children under 14 years of age presenting with signs and symptoms of SA or OM from 1 June 2009 to 31 June 2010 were subjected to standard blood tests with the addition of PCT. The definitive diagnosis was made by clinical, surgical and microbiologic data obtained. A cut-off level of 0.2 ng/mL was used. RESULTS: Thirty-three patients were included from which 12 were subdivided into the SA/OM group and 21 into an Other diagnosis group which acted as a control. Of the 12 patients in the SA/OM group, eight patients were diagnosed with SA and four with OM. In the SA/OM group, 11 from 12 patients had an increased PCT level compared to four in the Other diagnosis group. The calculated sensitivity of PCT was 92% with a confidence interval of 62-100%; the specificity was 81% with a confidence interval of 58-95%. In this study the sensitivity of CRP was 100% while the specificity 26%. The positive predictive value for PCT in this study was 73% and the negative predictive value was 94%. The accuracy for PCT in SA and OM in this study was 85%. CONCLUSIONS: The calculated sensitivity and specificity in this study has proved that PCT testing can aid in the diagnosis of SA/OM in children by using 0.2 ng/mL as cut-off level. PCT is also more specific for bacterial infections in this study compared to CRP. Staphylococcus aureus is the most common organism isolated in this series with no resistant organisms seen. Further research is needed with larger numbers to conclusively prove that this specific cut-off for PCT is significant.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[procalcitonin]]></kwd>
<kwd lng="en"><![CDATA[septic arthritis]]></kwd>
<kwd lng="en"><![CDATA[osteomyelitis]]></kwd>
<kwd lng="en"><![CDATA[diagnosis]]></kwd>
<kwd lng="en"><![CDATA[children]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>CLINICAL    ARTICLE</b></font></p>     <p>&nbsp;</p>     <p><a name="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Is    procalcitonin useful in diagnosing septic arthritis and osteomyelitis in children?</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>E Greeff MBChB(UP);    MMed(Orth)(UFS)</b> </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Registrar, Department    of Orthopaedics, University of the Free State, Bloemfontein</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Reprint    requests</a></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>BACKGROUND:</b>    Early diagnosis of septic arthritis (SA) and osteomyelitis (OM) in children    is essential to prevent long-term sequelae. The diagnosis for these orthopaedic    emergencies can be difficult and challenging especially in infants. Standard    blood tests used for diagnosis have a low specificity. Procalcitonin (PCT) is    significantly elevated in bacterial infections and remains low in viral infections    and inflammatory conditions. Good positive predictive values for PCT have been    obtained in various studies used in paediatric infections but limited studies    have examined the role in orthopaedic infections.    <br>   <b>METHOD:</b> All children under 14 years of age presenting with signs and    symptoms of SA or OM from 1 June 2009 to 31 June 2010 were subjected to standard    blood tests with the addition of PCT. The definitive diagnosis was made by clinical,    surgical and microbiologic data obtained. A cut-off level of 0.2 ng/mL was used.    <br>   <b>RESULTS:</b> Thirty-three patients were included from which 12 were subdivided    into the SA/OM group and 21 into an Other diagnosis group which acted as a control.    Of the 12 patients in the SA/OM group, eight patients were diagnosed with SA    and four with OM. In the SA/OM group, 11 from 12 patients had an increased PCT    level compared to four in the Other diagnosis group. The calculated sensitivity    of PCT was 92% with a confidence interval of 62-100%; the specificity was 81%    with a confidence interval of 58-95%. In this study the sensitivity of CRP was    100% while the specificity 26%. The positive predictive value for PCT in this    study was 73% and the negative predictive value was 94%. The accuracy for PCT    in SA and OM in this study was 85%.    <br>   <b>CONCLUSIONS:</b> The calculated sensitivity and specificity in this study    has proved that PCT testing can aid in the diagnosis of SA/OM in children by    using 0.2 ng/mL as cut-off level. PCT is also more specific for bacterial infections    in this study compared to CRP. <i>Staphylococcus aureus</i> is the most common    organism isolated in this series with no resistant organisms seen. Further research    is needed with larger numbers to conclusively prove that this specific cut-off    for PCT is significant.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Key words:</b>    procalcitonin, septic arthritis, osteomyelitis, diagnosis, children</font></p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Introduction</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Early diagnosis    of septic arthritis (SA) and osteomyelitis (OM) in children is essential in    preventing long-term sequelae from these infections, especially if the hip is    involved. Acute SA can be difficult to diagnose in children especially neonates    because the inflammatory response is blunted and signs such as fever, swelling,    erythema and pain may be minimal or lacking. Infection at another site (e.g.    umbilical catheter), irritability, failure to thrive, asymmetry of a limb position,    or displeasure at being handled, may be the only finding in a neonate.<sup>1-5</sup></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The white blood    cell count (WBC) is often normal but the erythrocyte sedimentation rate (ESR)    and C-reactive protein (CRP) are usually elevated. The problem with the ESR    is that it is non-specific and can be elevated in various conditions such as    inflammatory diseases, rheumatic diseases, liver and kidney diseases, neoplasms,    dysproteinaemias and anaemia. CRP can also be low in the early phase of acute    systemic bacterial infections and is often still low in bacterial abscesses.    CRP can also be elevated in viral infections, rheumatological diseases or tissue    damage, for example, trauma and surgery. CRP thus reflects disease activity    without a bacterial infection needing to be present. Levine <i>et al</i> confirmed    that CRP is a better independent predictor of SA than ESR.<sup>6</sup> Standard    radiographs are generally negative initially but may show soft tissue swelling.    Negative cultures are also common in early SA and OM. Ultrasound is inexpensive    and convenient and can show intra-articular fluid and abscess formation. A bone    scan can confirm the diagnosis 24 to 48 hours after onset in 90 to 95% of patients.    MRI can show early inflammatory changes as well as joint fluid and intra- or    subperiosteal abscesses. The last two tests are valuable in diagnosing infection    but are expensive and time-consuming, possibly leading to a delay in treatment.    Li <i>et al</i> confirmed that joint WBC is a better diagnostic test for SA    compared to WBC and ESR; however, neither test was diagnostic.<sup>7</sup> Aspiration    of a suspected septic joint is helpful to confirm the diagnosis but is usually    very painful and shouldn't be done routinely outside the operating theatre.<sup>8-12</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Procalcitonin (a    116-aminoacid peptide) is a precursor of calcitonin. Procalcitonin (PCT) is    significantly elevated in bacterial infections, but usually only slightly or    moderately elevated in viral infections and non-infectious inflammatory diseases.    PCT can be produced by several cell types and many organs in response to pro-inflammatory    stimuli, in particular bacterial products without increasing calcitonin. PCT    has the highest diagnostic accuracy where levels rise rapidly within 6-12 hrs    after an infectious insult with systemic consequences compared to CRP only increasing    after 12 hrs after onset of fever. Levels above 2 ng/mL are associated with    increased likelihood of the presence of bacterial sepsis. If the level is between    0.5 and 2 ng/mL, a systemic infection cannot be excluded and the PCT should    be repeated in 6-24 hrs. An increased level of PCT often correlates with the    severity of the disease and mortality.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Most studies have    only used PCT in other paediatric infections such as pneumonia and urinary tract    infections and not SA or OM. Recent studies using PCT for these emergency orthopaedic    infections suggested further work be done and a specific cut-off level determined    for these infections.<sup>13-20</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The aim of this    study is to introduce PCT testing in the initial workup of paediatric orthopaedic    infections, and to see:</font></p> <ul>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">if it is useful      in the diagnosis of orthopaedic infections</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">whether it could      replace the ESR or CRP</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">what is the      most accurate diagnostic level.</font></li>     </ul>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Patients and    methods</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A cross-sectional    prospective study to determine PCT levels in all children younger than 14 years    of age who presented at Pelonomi Hospital from 1 June 2009 to 31 June 2010 with    signs and symptoms of acute OM or SA was performed. Thirty-three patients were    included in the study. Standard workup included clinical examination, laboratory    blood tests and X-rays. The laboratory tests were an FBC, CRP and ESR. The diagnosis    was confirmed by clinical signs, the finding of pus at arthrotomy of the involved    joint or aspiration and drilling of the bone in theatre and microscopy, culture,    and sensitivity (MCS) of material (pus, tissue).</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The doctors responsible    for initial workup of these patients completed a short data sheet and added    PCT to the standard blood tests; no extra blood was required. Blood samples    were taken before antibiotic administration. PCT tests were performed with the    BRAHMS PCT sensitive kit. The researcher followed these patients up noting the    diagnosis and PCT level. The data sheets were collected weekly by the researcher    and then analysed at the end of the study period.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The only additional    expense was R300 for each PCT test. Sponsorship from Humor Diagnostics, the    company supplying the reagents, was requested to offset these costs.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Approval for the    study was obtained from the Ethics Committee of the University of the Free State.    All patient data were recorded anonymously under a hospital number. Consent    was obtained from the head of Pelonomi Hospital, Head of the Orthopaedic Department    and the</font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">NHLS.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Results were analysed    by the Department of Biostatistics UFS and summarised by means, standard deviations    or percentiles (numerical variables) and frequencies and percentages (categorical    variables). The sensitivity of PCT was calculated with a 95% confidence interval.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Results</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">PCT tests were    done on all 33 cases using the BRAHMS PCT sensitive kit and subdivided into    a SA/OM group and Other diagnosis group which acted as a control. The diagnosis    of SA was made in eight patients and OM in four patients. The PCT results are    summarised in <i><a href="#t1">Table I</a>.</i> In this study using PCT as a    diagnostic aid for SA or OM the calculated sensitivity was 92% with a confidence    interval of 62-100% <i>(<a href="#t2">Table II</a></i>). The specificity was    81% with a confidence interval of 58-95%. A cut-off value of 0.2 ng/mL was used    in this study. The mean PCT value was 25.04 ng/mL in the SA/OM group ranging    from 0.1 to 267 ng/mL. If a cut-off value of 0.5 ng/mL was used the sensitivity    would change to 75% and the specificity to 90% and a cut-off of 0.1 ng/mL the    sensitivity would change to 100% and the specificity to 76% in this study. The    positive predictive value for PCT in this study was 73% with a confidence interval    of 45-92%. The negative predictive value for PCT in this study was 94% with    a confidence interval of 73-100%. The accuracy for PCT in SA and OM in this    study was 85%.</font></p>     <p><a name="t1"></a></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/saoj/v11n1/09t01.jpg"></p>     <p>&nbsp;</p>     <p><a name="t2"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/saoj/v11n1/09t02.jpg"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">CRP levels were    done in all 12 cases in the SA/OM group and all the test levels were elevated.    Nineteen CRP tests were done out of 21 in the Other diagnosis group and 14 cases    were elevated and five normal. The calculated sensitivity of CRP in this study    was 100%, while the specificity was 26%.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In 11 of 12 cases    in the SA/OM group, material (pus, tissue) was sent for MCS. In ten cases bacteria    were isolated; <i>Staphylococcus aureus</i> was the most common organism and    was cultured in eight cases. All of these, <i>Staphylococci</i> were sensitive    to cloxacillin.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The early diagnosis    of SA and OM is essential in avoiding severe complications.<sup>1,4,6,7,11,21,22,23</sup>    With the importance of early treatment of these patients in mind the diagnosis    still remains a challenge. Various methods have been developed and researched    to assist the doctor in making the diagnosis but have failed to attain high    specificity.<sup>14,21</sup> Procalcitonin is a marker of bacterial infection    and has proven efficacy used in children with meningitis, pneumonia and urinary    tract infections. Procalcitonin rises rapidly in bacterial infections compared    to viral infections and other inflammatory conditions where PCT levels remain    low.<sup>13,21</sup> Previous studies comparing PCT and CRP in severe invasive    bacterial infections reported higher sensitivities and specificities.<sup>20</sup>    Limited studies have examined the role of using procalcitonin in these orthopaedic    emergencies to date and have struggled to find the ideal cut-off level.<sup>14</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The research question    was to find out if procalcitonin can aid in the diagnosis of SA and acute OM    in children and our study has shown this test to be a useful marker in these    infections. The calculated sensitivity of PCT in this study was 92% and the    specificity 81%. The positive predictive value for PCT was 73% and the negative    predictive value was 94% with an accuracy of 85%. These results are an improvement    compared to previous stud-ies.<sup>13,14,21</sup> PCT levels appeared more useful    than CRP in diagnosing OM or SA in our patients <i>(<a href="#t2">Table II</a>).</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Only four similar    studies have been performed to date. The first study, by Butbul-Aviel,<sup>13</sup>    evaluated PCT values in 44 patients presenting to hospital with fever, limping    and suspicion of SA or OM. In this study the calculated sensitivity for PCT    was 43.5% and specificity of 100% in bone and joint infections.<sup>13</sup>    The low sensitivity in the Butbul-Aviel study was due to a specific test and    cut-off level used in the study. They used a semi-quantitative rapid immunoassay    (BRAHMS PCT-Q, Hennigsdorf, Germany) which is a bedside test that can be done    in 30 minutes. This specific test has a low sensitivity with poor discrimination    of values around threshold levels and can only be divided into four categories.    The results are semi-quantitative and could only be divided into less than 0.5    ng/mL, 0.5 ng/mL-2 ng/mL, 2-10 ng/mL, and more than 10 ng/mL. In this study    the authors could not evaluate specific PCT values with their calculated sensitivity    and specificity and could only use 0.5 ng/mL as a cut-off level. The Butbul-Aviel    study concluded that PCT seems to be a promising marker more for acute OM than    for SA and that further research is needed.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Faesch <i>et al<sup>21</sup></i>    evaluated PCT levels in 339 patients presenting in a paediatric emergency department    for suspected OM or SA. All patients presenting with nontraumatic decreased    active motion of a skeletal segment with or without fever were included. The    ages ranged from 1 month to 14 years and were divided into three groups.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The first group    had confirmed infection with a positive culture and the second presumed infection    without positive culture but positive infective markers, purulent bone or joint    fluid aspiration or positive scintigraphy. The third group was the non-infected    patients with negative markers and normal X-rays and ultrasound. These groups    were then compared to each other. Group 1 comprised eight patients, group 2    had 40 patients and group 3 had 291 patients. Comparing group 1 with group 3    the specificity of PCT used as marker of bacterial infection was 96.9%, the    sensitivity 25%, the positive predictive value 18.2% and the negative predictive    value 97.9%.<sup>21</sup> Compared to the Butbul-Aviel study, the sensitivity    of PCT was lower but the specificity similar. In the Faesch study a more sensitive    PCT test was used where values can range from 0.06 to 50 ng/mL. The same test    was used in our study. There are two limitations to the Faesch study. Children    with a history of trauma were excluded from the study and as this often precedes    OM, as in 25% of our cases, some OM cases may have been excluded distorting    the results.<sup>1,4,22</sup> Another problem is the very low incidence of positive    bacteriological findings which raises some doubts about the accuracy of the    investigation and the conclusions drawn.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Fottner <i>et al<sup>14</sup></i>    examined PCT and CRP values in 33 patients who presented with symptoms of acute    arthritis of unknown origin at their emergency department. The more sensitive    PCT test was used, as in the study by Faesch with a cut-off level again of 0.5    ng/mL. Fifteen patients were diagnosed with SA on the basis of microbiological    cultures. The calculated sensitivity of PCT in this series was 53.3% with a    specificity of 100%. CRP levels in both septic and non-septic arthritis groups    were not within normal limits and resulted in a specificity of 0%.<sup>14</sup>    The sensitivity in this study is similar to the previous two studies concluding    that using 0.5 ng/mL as the cut-off level for PCT is not reliable to distinguish    between septic and non-septic arthritis. However they found that lowering the    cutoff level improved the diagnostic value of PCT, and by using a cut-off of    0.2 ng/mL they attained a sensitivity of 100% and a specificity of 94.4%. Another    study by H&uuml;gle<sup>15</sup> also used a lower cut-off and attained improved    sensitivity and specificity for diagnosing joint infections. These findings    were also proven in our study where 0.2 ng/mL was also used as the cut-off level    for PCT with a much improved sensitivity of 92% and specificity of 81% compared    to the previous studies. Using a cut-off level of 0.2 ng/mL for PCT has also    achieved a sensitivity and specificity of up to 100% in the diagnosis of bacterial    meningitis.<sup>17</sup> These findings support the conclusion that by lowering    the cut-off level of PCT to 0.2 ng/mL, a more accurate diagnosis of bone and    joint infection can be made.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">CRP was done in    all the cases in the bone or joint infection group and all results were raised.    CRP was also raised in 14 of 19 cases in the Other diagnosis group. This finding    was also seen in the Fottner study and signifies the low specificity of CRP    in diagnosing bone or joint infections.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The most common    organism isolated was <i>Staphy/ococcus aureus</i> in 80% of cases in the bone    or joint infection group and was sensitive to cloxacillin in all cases. No resistant    organisms were seen. This finding correlates with current literature.<sup>1,9,21,22,24</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There are a few    limitations to this study. Further studies will need to be done with larger    number of cases to improve the confidence interval of using PCT in bone and    joint infections as well as to use the more accurate cut-off of 0.2 ng/mL. Another    limitation is whether the human immunodeficiency virus (HIV) has an influence    on PCT results. The one case of SA of the knee, known with HIV, had a normal    PCT result. No conclusion can be made because not all the cases were tested    for HIV but definite further research in this field is needed especially because    there is such a high prevalence of HIV in Southern Africa.<sup>25</sup> Also    in the Other diagnosis group four patients had increased PCT levels of which    two needed drainage of abscesses and two intravenous antibiotics to control    soft tissue infections. This means that the false positive patients still needed    acute surgical or medical management. PCT tests are not cheap and cost approximately    R300 a test and $50 in the USA compared to other infective markers. No research    has been done on the cost-effectiveness of PCT and it is speculated in one paper    that PCT can reduce hospital admissions, theatre time and antibiotic usage.<sup>20</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Certain recommendations    can be made after considering the results of this study. PCT is more accurate    in diagnosing bone and joint infections if a lower cut-off level of 0.2 ng/mL    is used. This finding is proved in our study and in Fottner and H&uuml;gle's    papers. In the literature much work has been done creating prediction rules    to aid the doctor to distinguish between SA and transient synovitis of the hip.    Since Kocher <i>et a/<sup>23</sup></i> started work in 1999 on clinical prediction    rules, an evolution of these rules have been made, and Caird <i>et a/<sup>26</sup></i>    in 2006 refined the rules. They used the following predictors to aid the diagnosis    of SA:</font></p> <ul>       ]]></body>
<body><![CDATA[<li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Temperature      &gt; 38.5 &deg;C</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">CRP &gt; 2.0      mg/L</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">ESR &gt; 40      mm/hr</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Refusal to bear      weight</font></li>       <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">WCC &gt; 12      000/mm<sup>3</sup></font></li>     </ul>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The probability    of SA when using these prediction rules is 16.9% for zero predictors, 36.7%    for one predictor, 62.4% for two predictors, 82.6% for three predictors, 93.1%    for four predictors, and 97.5% for five predictors.<sup>26</sup> After PCT efficacy    has been finally proven in bone and joint infections addition into these prediction    rules can aid the diagnosis of these emergencies. PCT levels often correlate    with the degree of microbial invasion and decrease rapidly with the addition    of antibiotics.<sup>20</sup> With a rapid PCT reaction to treatment in mind    further research can be done to evaluate PCT effectiveness as a response marker    to treatment.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Conclusions</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Procalcitonin testing    can aid in the early diagnosis of SA or acute OM in children by lowering the    cut-off level from 0.5 ng/mL to 0.2 ng/mL. This finding was proven in our study    with a sensitivity of 92% and a specificity of 81% as well as in Fottner and    Hugle's research. Procalcitonin is more specific for bacterial infections compared    to CRP and rises more rapidly than the latter.</font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Acknowledgements</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Thank you to Prof    JA Shipley for guidance and advice and to all my colleagues who participated    in the study.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>This article    is the sole work of the author. No benefits in any form have been received or    will be received from a commercial party related directly or indirectly to the    subject of this article.</i></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Dlabach JA,    Park AL. Infectious arthritis. In: Canale ST, Beaty JH. Campbell's Operative    Orthopaedics.llth edition. Philadelphia: Mosby Elsevier; 2008. p. 723-50.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451756&pid=S1681-150X201200010000900001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Staheli LT.    Practice of Pediatric Orthopedics. 2nd edition. Philadelphia: Lippincott Williams    and Wilkins; 2006.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451757&pid=S1681-150X201200010000900002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Chapman MW Chapman's    Orthopaedic Surgery. 3rd edition. Philadelphia: Lippincott Williams and Wilkins;    2001.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451758&pid=S1681-150X201200010000900003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Dabov GD. Osteomyelitis.    In: Canale ST, Beaty JH. Campbell's Operative Orthopaedics.llth edition. Philadelphia:    Mosby Elsevier; 2008. p. 695-702.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451759&pid=S1681-150X201200010000900004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Min-Kyu N, Ka    Em K, Chung-Hung W Septic arthritis and acute osteomyelitis in early infancy.    <i>Clinical Neonatology</i> 1999;6(2):9-13.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451760&pid=S1681-150X201200010000900005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Levine M, McGuire    K, McGowan K, Flynn J. Assessment of the test characteristics of C-reactive    protein for septic arthritis in children. <i>J Pediatric Orthop</i> 2003;23(3):373-77.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451761&pid=S1681-150X201200010000900006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Li SF, Cassidy    C, Chang C, Gharib S, Torres J. Diagnostic utility of laboratory tests in septic    arthritis. <i>Emerg Med J</i></font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">2007;24(2):75-77.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451762&pid=S1681-150X201200010000900007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Siegenthaler    W. Differential diagnosis in Internal Medicine. 1st English edition. New York:Thieme;    2007.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451763&pid=S1681-150X201200010000900008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Mathews CJ,    Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. <i>Curr    Opin Intern Med</i></font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">2008;7(5):532-37.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451764&pid=S1681-150X201200010000900009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Mathews CJ,    Kingsley G, Field M, Jones A, Weston VS, Phillips M, <i>et al.</i> Management    of septic arthritis: a systemic review. <i>Postgrad Med J</i> 2008;84(991):265-70.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451765&pid=S1681-150X201200010000900010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Jung ST, Rowe    SM, Moon ES, Song EK, Yoon TR, Seo HY. Significance of laboratory and radiologic    findings for differentiating between septic arthritis and transient synovitis    of the hip. <i>J Pediatric Orthop</i> 2003;23(3):368-72.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451766&pid=S1681-150X201200010000900011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Bonhoeffer    J, Haerberle B, Schaad BS, Heininger U. Diagnosis of acute haemotogenous osteomyelitis    and septic arthritis: 20 years' experience at the University children's hospital    Basel. <i>Swiss Med Wkly</i> 2001;131:575-81.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451767&pid=S1681-150X201200010000900012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Butbul-Aviel    Y, Koren A, Halevy R, Sakran W Procalcitonin as a diagnostic aid in osteomyelitis    and septic arthritis. <i>Pediatr Emerg Care</i> 2005;21(12):828-23.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451768&pid=S1681-150X201200010000900013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Fottner A,    Birkenmaier C, Von Schulze P, Bernd W, Volkmar J. Can serum procalcitonin help    to differentiate between septic and nonseptic arthritis? <i>Arthroscopy</i></font>    <font face="Verdana, Arial, Helvetica, sans-serif" size="2">2008;24(2):229-33.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451769&pid=S1681-150X201200010000900014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15. H&uuml;gle    T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass C. Serum procalcitonin    for discrimination between septic and non-septic arthritis. <i>Clin Exp Rheumatol</i>    2009;26(3):453-56.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451770&pid=S1681-150X201200010000900015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16. BRAHMS. Guide    for the clinical use of procalcitonin (pct) in diagnosis and monitoring of sepsis.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451771&pid=S1681-150X201200010000900016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Carrol ED,    Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. <i>Int J Antimicrob    Agents</i> 2002;20(1):1-9.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451772&pid=S1681-150X201200010000900017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Meisner M.    Procalcitonin: A new, innovative infection parameter. Biochemical and clinical    aspects. 3rd edition.</font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">New    York:Thieme 2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451773&pid=S1681-150X201200010000900018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Maniaci V,    Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile    infants for the detection of serious bacterial infections. <i>Pediatrics</i>    2008;122(4):701-10.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451774&pid=S1681-150X201200010000900019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20. Van Rossum    AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection    in neonates and children. <i>Lancet Infect Dis</i> 2004;4(10):620-30.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451775&pid=S1681-150X201200010000900020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21. Faesch S, Cojocaru    B, Hennequin C, Pannier S, Glorion C, Lacour B, <i>et al.</i> Can procalcitonin    measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective    trial. <i>Ital J Pediatr</i> 2009;35(1):1-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451776&pid=S1681-150X201200010000900021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22. Stans AA. Osteomyelitis    and septic arthritis. In: Morrissy RT, Weinstein SL. Lovell and Winter's Pediatric    Orthopaedics. 6th edition. Philadelphia: Lippincott Williams &amp; Wilkins;    2006. pp. 440-91.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451777&pid=S1681-150X201200010000900022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23. Kocher MS,    Zurakowski D, Kasser JR. Differentiating between septic and transient synovitis    of the hip in children: an evidence-based clinical prediction algorithm. <i>J    Bone Joint Surg Am</i> 1999 Dec; 81(12):1662-70.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451778&pid=S1681-150X201200010000900023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24. Visser HF,    Visser A, Goller K, Goller R, Nel JM, Snyckers CH. Paediatric septic arthritis    in a tertiary setting: A retrospective analysis. <i>SAOA.</i> 2010;9(2):92-96.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451779&pid=S1681-150X201200010000900024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25. UNAIDS Global    report 2010 &#91;homepage on the internet&#93;. World Health Organization 2009.    Available from:<a href="http://www.unaids.org/globalreport/HIV_prevalence_map.htm">http://www.unaids.org/globalreport/HIV_prevalence_map.htm</a>.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451780&pid=S1681-150X201200010000900025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">26. Caird MS, Flynn    JM, Leung YL, Millman JE, d'Italia JG, Dormans JP. Factors distinguishing septic    arthritis from transient synovitis of the hip in children. A prospective study.    <i>J Bone Joint Surg Am</i> 2006 Jun;88(6):1251-57.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=451781&pid=S1681-150X201200010000900026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><a href="#top"><img src="/img/revistas/saoj/v11n1/seta.jpg" border="0">    </a>Reprint requests:    <br>   </b> Dr E Greeff    <br>   Postnet Suite 273    <br>   Private Bag X87    <br>   Bryanston 2021    <br>   Cell: 082 927 0568    ]]></body>
<body><![CDATA[<br>   Email: <a href="mailto:egreeff@lantic.net">egreeff@lantic.net</a></font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dlabach]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infectious arthritis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Canale]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Beaty]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<source><![CDATA[Campbell's Operative Orthopaedics]]></source>
<year>2008</year>
<edition>llth</edition>
<page-range>723-50</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Mosby Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Staheli]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
</person-group>
<source><![CDATA[Practice of Pediatric Orthopedics]]></source>
<year>2006</year>
<edition>2nd</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams and Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
</person-group>
<source><![CDATA[Chapman's Orthopaedic Surgery]]></source>
<year>2001</year>
<edition>3</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams and Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dabov]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Osteomyelitis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Canale]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Beaty]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<source><![CDATA[Campbell's Operative Orthopaedics]]></source>
<year>2008</year>
<edition>llth</edition>
<page-range>695-702</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Mosby Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Min-Kyu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ka Em]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chung-Hung]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Septic arthritis and acute osteomyelitis in early infancy]]></article-title>
<source><![CDATA[Clinical Neonatology]]></source>
<year>1999</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>9-13</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McGuire]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Flynn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assessment of the test characteristics of C-reactive protein for septic arthritis in children]]></article-title>
<source><![CDATA[J Pediatric Orthop]]></source>
<year>2003</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>373-77</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Cassidy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gharib]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diagnostic utility of laboratory tests in septic arthritis]]></article-title>
<source><![CDATA[Emerg Med J]]></source>
<year>2007</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>75-77</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siegenthaler]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Differential diagnosis in Internal Medicine]]></source>
<year>2007</year>
<edition>1st</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Thieme]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathews]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Coakley]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Septic arthritis: current diagnostic and therapeutic algorithm]]></article-title>
<source><![CDATA[Curr Opin Intern Med]]></source>
<year>2008</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>532-37</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathews]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kingsley]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Field]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weston]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Management of septic arthritis: a systemic review]]></article-title>
<source><![CDATA[Postgrad Med J]]></source>
<year>2008</year>
<volume>84</volume>
<numero>991</numero>
<issue>991</issue>
<page-range>265-70</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Rowe]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Seo]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Significance of laboratory and radiologic findings for differentiating between septic arthritis and transient synovitis of the hip]]></article-title>
<source><![CDATA[J Pediatric Orthop]]></source>
<year>2003</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>368-72</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonhoeffer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Haerberle]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schaad]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Heininger]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diagnosis of acute haemotogenous osteomyelitis and septic arthritis: 20 years' experience at the University children's hospital Basel]]></article-title>
<source><![CDATA[Swiss Med Wkly]]></source>
<year>2001</year>
<volume>131</volume>
<page-range>575-81</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butbul-Aviel]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Koren]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Halevy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sakran]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis]]></article-title>
<source><![CDATA[Pediatr Emerg Care]]></source>
<year>2005</year>
<volume>21</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>828-23</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fottner]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Birkenmaier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Von Schulze]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bernd]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Volkmar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Can serum procalcitonin help to differentiate between septic and nonseptic arthritis?]]></article-title>
<source><![CDATA[Arthroscopy]]></source>
<year>2008</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>229-33</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hügle]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Schuetz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Laifer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tyndall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Regenass]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Serum procalcitonin for discrimination between septic and non-septic arthritis]]></article-title>
<source><![CDATA[Clin Exp Rheumatol]]></source>
<year>2009</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>453-56</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[BRAHMS]]></surname>
</name>
</person-group>
<source><![CDATA[Guide for the clinical use of procalcitonin (pct) in diagnosis and monitoring of sepsis]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrol]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[Thomson]]></surname>
<given-names><![CDATA[APJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Procalcitonin as a marker of sepsis]]></article-title>
<source><![CDATA[Int J Antimicrob Agents]]></source>
<year>2002</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meisner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Procalcitonin: A new, innovative infection parameter]]></source>
<year>2000</year>
<edition>3rd</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Thieme]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maniaci]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dauber]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nylen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Bachur]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Procalcitonin in young febrile infants for the detection of serious bacterial infections]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2008</year>
<volume>122</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>701-10</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Rossum]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Wulkan]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Oudesluys-Murphy]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Procalcitonin as an early marker of infection in neonates and children]]></article-title>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2004</year>
<volume>4</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>620-30</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faesch]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cojocaru]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hennequin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pannier]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Glorion]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lacour]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis?: A prospective trial]]></article-title>
<source><![CDATA[Ital J Pediatr]]></source>
<year>2009</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stans]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Osteomyelitis and septic arthritis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Morrissy]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Weinstein]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<source><![CDATA[Lovell and Winter's Pediatric Orthopaedics]]></source>
<year>2006</year>
<edition>6th</edition>
<page-range>440-91</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams & Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kocher]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Zurakowski]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kasser]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differentiating between septic and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>1999</year>
<month> D</month>
<day>ec</day>
<volume>81</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1662-70</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Visser]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Visser]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Goller]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Goller]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nel]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Snyckers]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Paediatric septic arthritis in a tertiary setting: A retrospective analysis]]></article-title>
<source><![CDATA[SAOA]]></source>
<year>2010</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>92-96</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>UNAIDS</collab>
<source><![CDATA[Global report 2010 [homepage on the internet]: World Health Organization]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caird]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Flynn]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Millman]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[d'Italia]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Dormans]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Factors distinguishing septic arthritis from transient synovitis of the hip in children: A prospective study]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2006</year>
<month> J</month>
<day>un</day>
<volume>88</volume>
<page-range>1251-57</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
